Noorik Biopharmaceuticals AG
3 clinical trials · Sponsor
◉ Watch Noorik Biopharmaceuticals AG
| Record | Firm | Date |
|---|---|---|
| Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome (NCT06256432) | Noorik Biopharmaceuticals AG | 2024-04-17 |
| A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19 (NCT04771000) | Noorik Biopharmaceuticals AG | 2021-02-08 |
| A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis (NCT03827200) | Noorik Biopharmaceuticals AG | 2019-04-11 |
Track Noorik Biopharmaceuticals AG automatically
Every clearance here is in the API, with alerts when new ones post.